Genetics of primary headaches

Current Opinion in Neurology

Volumn 12, Issue 3, 1999, Pages 249-254

  Kors, Esther E ^a   Haan, Joost ^a,b   Ferrari, Michel D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNLAND HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; MITOCHONDRIAL DNA; PROTHROMBIN;

AUTOSOMAL DOMINANT DISORDER; CEREBELLAR ATAXIA; CHROMOSOME 19P; CLUSTER HEADACHE; DISEASE CLASSIFICATION; EPILEPSY; FAMILIAL DISEASE; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; HEADACHE; HEMIPLEGIA; HEREDITY; HUMAN; MIGRAINE; MITOCHONDRION; RAYNAUD PHENOMENON; RETINOPATHY; REVIEW; RISK FACTOR; TENSION HEADACHE; THROMBOSIS; X CHROMOSOME LINKAGE;

HUMANS; MIGRAINE DISORDERS;

EID: 0032794044     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199906000-00002     Document Type: Review

References (44)

1. Terwindt GM, Ophoff RA, Haan J, Sandkuijl LA, Frants R, Ferrari MD, for the Dutch Migraine Genetics Research Group. Migraine, ataxia and epilepsy: a challenging spectrum of genetic determined calcium channelopathies. Eur J Hum Genet 1998; 6:297-307. This is a review of calcium channel gene mutations in migraine, ataxia and epilepsy in mice and humans.
2. Gardner K, Hoffman EP. Current status of genetic discoveries in migraine: familial hemiplegic migraine and beyond. Curr Opin Neurol 1998; 11:211-216.
3. Østergaard S, Russell MB, Berndtsen L, Olesen J. Comparison of first degree relatives and spouses of people with chronic tension headache. Br Med J 1998; 314:1092-1093. The first evidence is presented that genetic factors may play a role in TTH.
4. Russell MB, Iselius L, Østergaard S, Olesen J. Inheritance of chronic tension- type headache investigated by complex segregation analysis. Hum Genet 1998; 102:138-140.
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pains. Cephalalgia 1988; 8:1-96.
6. May A, Bahra A, Büchel C, Frackowiak, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352:275-278. This is the first evidence that central cerebral structures are involved in cluster headache. It is, however, not known whether this involvement occurs primarily (as the cause of cluster headache) or secondarily (caused by cluster headache)
7. May A, Goadsby PJ. Cluster headache: Imaging and other developments. Curr Opin Neurol 1998; 11:199-203.
8. Montagna P, Mochi M, Prologo G, Sangiorgi S, Pierangeli G, Cevoli G, et al. Heritability of cluster headache. Eur J Neurol 1998; 5:343-345.
9. Haan J, Terwindt GM, Ferrari MD. Genetics of migraine. Adv Headache 1997; 15:43-60.
10. Ziegler DW, Hur YM, Bouchard TJ, Hassanein RS, Barter R. Migraine in twins raised together and apart. Headache 1998; 38:417-422.
11. 2+ channel gene CACNL1A4. Cell 1996; 87:543-552.
12. Terwindt GM, Ophoff RA, Haan J, Vergouwe MN, van Eijk R, Frants RR, et al. Variable clinical expression of mutations in the P/O type calcium channel gene in familial hemiplegic migraine. Neurology 1998; 50:1105-1110. A genotype - phenotype comparison of FHM families with different mutations is provided. Cerebellar ataxia seems to be a specific symptom of certain mutations; some patients with typical migraine had mutations; and several phenocopies were found.
13. Klockgether T, Evert B. Genes involved in hereditary ataxias. Trends Neurosci 1998; 21: 412-418. A good review is presented of the genetics of episodic and chronic ataxia.
14. Yue Q, Jen JC, Thwe MM, Nelson SF, Baloh RW. De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia. Am J Med Genet 1998; 77:298-301. This report expands the spectrum of phenotypes caused by CACNA1A gene mutations.
15. Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calandriello L, et al. Episodic ataxia type 2 (EA2) and spinocerebellar taxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 1997; 11:1973-1978.
16. Yue Q, Jen JC, Nelson SF, Baloh RW. Progressive ataxia due to a missense mutation in a calcium-channel gene. Am J Hum Genet 1997; 61:1078-1087.
17. Kim JS, Yue Q, Jen JC, Nelson SF, Baloh RW. Familial migraine with vertigo: no mutations found in CACNA1A. Am J Med Genet 1998; 79:148-150.
18. 2+ channel kinetics. J Biol Chem 1998; 273:5586-5590. This paper presents the first evidence that CACNA1A mutations alter the function of the gene. This finding can be of importance for further migraine research, as it potentially offers an in-vivo model to study the metabolism and effects of (new) migraine drugs.
19. 1A-containing calcium channels [abstract]. Soc Neurosci 1998; 24:21.
20. May A, Ophoff RA, Terwindt GM, Urban C, van Eijk R, Haan J, et al. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum Genet 1995; 96:604-608.
21. Nyholt DR, Lea RA, Goadsby PJ, Brimage PJ, Griffiths LR. Familial typical migraine. Linkage to chromosome 19p13 and evidence for genetic hetorogeneity. Neurology 1998; 50:1428-1432.
22. Terwindt GM, Haan J, Ophoff RA, Groenen SMA, Storimans CWJM, Lanser JBK, et al. Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain 1998; 121:303-316. This is a description of a large pedigree with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. This pedigree offers the possibility to study migraine genes.
23. Andermann F, Zifkin B. The benign occipital epilepsies of childhood: an overview of the idiopathic syndromes and of the relationship to migraine. Epilepsia 1998; 39(Suppl 4):S9-S23.
24. McEnery MW, Copeland TD, Vance CL. Altered expression and assembly of N-type calcium channel alpha1b and beta subunits in epileptic lethargic (lh/lh) mouse. J Biol Chem 1998; 273:21435-2438.
25. 2+ -channel gamma subunit. Nature Genet 1998; 19:340-347.
26. Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, et al. A novel potassium channel gene, KCWO2, is mutated in an inherited epilepsy of newborns. Nature Genet 1998; 18:25-29. See [28].
27. Charlier C, Singh NA, Ryan SG, Lewis TB, Reau BE, Leach RJ, Leppert M. A pore mutation in a novel KOT-like potassium channel gene in an idiopathic epilepsy family. Nature Genet 1998; 18:53-55. See [28].
28. +- channel beta 1 subunit gene SCB1B. Nat Genet 1998; 19:366-370. This paper and [26,27] establish that at least two types of idiopathic epilepsy are channelopathies.
29. Peroutka SJ. Dopamine and migraine. Neurology 1997; 49:650-656.
30. Peroutka SJ, Wilhoit T, Jones K. Clinical susceptibility to migraine with aura is modified by dopamine D2 receptor (DRD2) Ncol alleles. Neurology 1997; 49:201-206.
31. Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) Ncol alleles. Mol Med 1998; 4:14-21.
32. Dichgans M. Förderreuther S, Deiterich M, Pfaffenrath V, Gasser T. The 2 receptor Ncil allele: absence of alleleic association with migraine with aura [letter]. Neurology 1998; 51:928.
33. Del Zompo M, Cherchi A, Palmas MA, Ponti M, Bocchetta A, Gessa GL, et al. Association between dopamine receptor genes and migraine without aura in a Sardinian sample. Neurology 1998; 51:781-786.
34. Ferrari MD, Saxena PR. On serotonin and migraine: a clinical and pharmalogical review. Cephalalgia 1993; 13:151-165.
35. Ogilvie AD, Russell MB, Dhall P, Battersby S, Ulrich V, Smith CAD, et al. Altered allelic distributions of the serotonin transporter gene in migraine with and without aura. Cephalalgia 1998; 18:23-26.
36. MaassenVanDenBrink A, Vergouwe MN, Ophoff RA, Saxena PR, Ferrari MD, Frants RR. 5-HT1B receptor polymorphism and clinical respons to sumatriptan. Headache 1998; 38:288-291.
37. MaassenVanDenBrink A, Vergouwe MN, Ophoff RA, Naylor SL, Dauwerse HG, Saxena PR, et al. Chromosomal localization of the 5-HT1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients. Am J Med Genet 1998; 77:415-420.
38. Corral J, Iniesta JA, Gonzalez-Conejero R, Lozano ML, Rivera J, Vicente V. Migraine and prothrombotic genetic risk factors. Cephalalgia 1998; 18:257- 260.
39. Soriani S, Borgna-Pignatti C, Trabetti E, Casartelli A, Montagna P, Pignatti PF. Frequency of factor V Leiden in juvenile migraine with aura. Headache 1998; 38:779-781.
40. Haan J, Kappelle JL, Ferrari MD. The transition G to A at position 20210 in the ′3-untranslated region of the prothrombin gene is not associated with migrainous infarction. Cephalalgia 1998; 18:229-230.
41. Nyholt DR, Dawkins JL, Brimage PJ, Goadsby PJ, Nicholson GA, Griffiths LR. Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet 1998; 7:459-463. This is the first evidence that the X-chromosome plays a role in some migraine families.
42. Shimomura T, Kitano A, Marukawa H, Takahashi K. Mutation in platelet mitochondrial gene in patients with migraine [abstract]. Cephalalgia 1995; 15:10.
43. Russell MB, Diamant M, Norby S. Genetic heterogeneity of migraine with and without aura in Danes cannot be explained by mutation in mtDNA nucleotide pair 11084. Acta Neurol Scand 1997; 96:171-173.
44. Sakuta R, Goto Y, Nonaka I, Horai S. An A-to-G transition at nucleotide pair 11084 in the ND4 gene may be an mtDNA polymorphism. Am J Hum Genet 1993; 53:964-965.